Cahn A, Raz I, Bonaca M, Mosenzon O, et al. Safety of dapagliflozin in a broad population of patients with type 2 diabetes - analyses from the DECLARE - TIMI 58 study. Diabetes Obes Metab 2020 Apr 2. doi: 10.1111/dom.14041.
PMID: 32239659